Abpro, based in Woburn, MA, is a pioneering biopharmaceutical company dedicated to harnessing the power of the immune system to develop novel therapies for combating a range of diseases. Their cutting-edge technology platforms, DiversImmune and MultiMab, enable the discovery and engineering of antibodies to target and treat various medical conditions.
With a mission to lead the way in modern medicine, Abpro focuses on developing innovative treatments to address some of the most pressing health challenges of our time. Recent milestones include advancements in COVID-19 antibody therapeutics, demonstrating a commitment to advancing healthcare through research and development.
Generated from the website